Founders Fund V Management LLC bought a new position in shares of Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 480,708 shares of the company’s stock, valued at approximately $764,000. Cyclo Therapeutics accounts for 80.8% of Founders Fund V Management […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Free Report) – Analysts at HC Wainwright issued their Q1 2024 EPS estimates for Cyclo Therapeutics in a research note issued to investors on Wednesday, May 1st. HC Wainwright analyst S. Ramakanth expects that the company will post earnings of ($0.20) per share for the quarter. HC Wainwright has a […]
Cyclo Therapeutics (NASDAQ:CYTH) Earns Buy Rating from Analysts at Ascendiant Capital Markets themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 45,600 shares, a decrease of 59.5% from the March 15th total of 112,600 shares. Approximately 0.4% of the shares of the company are […]
Research analysts at Cowen initiated coverage on shares of Leafly (NASDAQ:LFLY – Get Rating) in a research report issued to clients and investors on Friday, The Fly reports. The brokerage set an “outperform” rating on the stock. Separately, Oppenheimer began coverage on shares of Leafly in a research report on Wednesday. They issued a “market […]